FdaApplication
ANDA 213317
Identifiers
- fda_app_no: ANDA213317
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2020-11-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GEMMILY | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | 0.02MG;1MG | CAPSULE;ORAL |
1 product